Neurological comorbidities and COVID-19-related case fatality: A cohort study.

"Financial disclusures and conflicts of interest Dr. Romagnolo has received grant support and speaker honoraria from AbbVie, speaker honoraria from Chiesi Farmaceutici and travel grants from Lusofarmaco, Chiesi Farmaceutici, Medtronic, and UCB Pharma. Dr. Imbalzano has no financial conflicts to disclose. Dr. Artusi has received travel grants from Zambon and Abbvie. Dr. Balestrino has no financial conflicts to disclose. Dr. Ledda has no financial conflicts to disclose. Prof De Rosa has no financial conflicts to disclose. Dr. Riccardini has no financial conflicts to disclose. Dr. Montanaro has received travel grant from Ralpharma. Prof Bozzali is member of the Advisory board of Roche Pharmaceuticals and has received honoraria for lecturing from Biogen Pharma. Dr. Rizzone has received grant support and speaker honoraria from Medtronic and UCB. Dr. Zibetti has received honoraria from Medtronic, Zambon Pharma and AbbVie. Prof Lopiano has received honoraria for lecturing and travel grants from Medtronic, UCB Pharma, and AbbVie."

"Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors."